Clinical Trials in Austin

Showing 6901-6920 of 15,205 trials

Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

NCT05245539

The purpose of this trial is to characterize the effects of 2 oral doses (over 8 weeks total) of CVL-231 on ambulatory blood pressure and heart rate in patients with stable schizophrenia.

Blood PressureSchizophrenia

Cerevel Therapeutics, LLC151 participantsStarted Jan 2022

Bentonville, Arkansas, United States • Little Rock, Arkansas, United States • Long Beach, California, United States +7 more locations

COMPLETEDPhase 1< 1 mile

A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet

NCT01287091

This will be a single-center, open-label, 3 part study. The study is designed to determine the relative bioavailability of GDC-0980 capsule and tablet formulations under fasting conditions, the effects of a high-fat (fed) meal on the pharmacokinetics of the GDC-0980 tablet, and the effects of rabeprazole on the pharmacokinetics of the GDC-0980 tablet in the presence or absence of a high-fat meal.

Healthy Volunteer

Genentech, Inc.46 participantsStarted Oct 2010

Austin, Texas, United States

Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet

Find Trials by Condition in Austin

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

Vitala 12 Hour Wear Test With Convex Products

Comparison Study of 3 Ostomy Products

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata